SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-019221
Filing Date
2023-05-09
Accepted
2023-05-09 10:00:20
Documents
15
Period of Report
2023-05-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-20230509.htm   iXBRL 8-K 77056
2 GRAPHIC img215258061_0.jpg GRAPHIC 89077
3 GRAPHIC img215258061_1.jpg GRAPHIC 43026
4 GRAPHIC img215258061_2.jpg GRAPHIC 29766
  Complete submission text file 0000950170-23-019221.txt   591959

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230509_lab.xml EX-101.LAB 12806
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230509.xsd EX-101.SCH 2478
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230509_pre.xml EX-101.PRE 9459
9 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230509_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 23900498
SIC: 2834 Pharmaceutical Preparations